thisdrug what a medicine's name tells you

WHO naming stem · suffix · 108 listed names

-mycin

This page was written with AI.

antibiotics, produced by Streptomyces strains (see also -kacin)

WHO's definition, quoted as written in the 2024 stem book

22 of 108 names appear in these lists: 22 in the US list (FDA Drugs@FDA) and 2 in the EU central list (EMA); 21 have national brands in at least one EU/EEA country.

Names only. This page is about -mycin as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -mycin. So the letters mycin sit at the end of the name (…mycin).

All 108 names WHO lists under -mycin

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 22 of 108 names appear in these lists: 22 in the US list (FDA Drugs@FDA) and 2 in the EU central list (EMA); 21 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. alvespimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. ambomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  3. amfomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. antelmycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  5. antramycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  6. apramycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  7. avilamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. azalomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  9. azithromycin
    US brands: AZASITE, ZITHROMAX, ZMAX (discontinued in FDA listings)
    in combination: TROVAN/ZITHROMAX COMPLIANCE PAK (discontinued in FDA listings) with trovafloxacin
    EU (central) brands: none found
  10. azotomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. bambermycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  12. bekanamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  13. berythromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  14. bicozamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  15. biniramycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  16. bleomycin
    US brands: BLENOXANE (discontinued in FDA listings)
    EU (central) brands: none found
  17. bluensomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  18. cactinomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  19. carbomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. cethromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  21. cirolemycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  22. clarithromycin
    US brands: BIAXIN (discontinued in FDA listings), BIAXIN XL (discontinued in FDA listings)
    in combination: LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED) with amoxicillin + lansoprazole; VOQUEZNA TRIPLE PAK with amoxicillin + vonoprazan; OMECLAMOX-PAK (discontinued in FDA listings) with amoxicillin + omeprazole; PREVPAC (COPACKAGED) (discontinued in FDA listings) with amoxicillin + lansoprazole
    EU (central) brands: none found
  23. clindamycin
    US brands: CLEOCIN, CLEOCIN HYDROCHLORIDE, CLEOCIN PHOSPHATE, CLEOCIN T, CLINDAGEL, CLINDESSE, XACIATO, CLINDA-DERM (discontinued in FDA listings), CLINDETS (discontinued in FDA listings), EVOCLIN (discontinued in FDA listings)
    in combination: ACANYA with benzoyl peroxide; CABTREO with adapalene + benzoyl peroxide; DUAC with benzoyl peroxide; ONEXTON with benzoyl peroxide; VELTIN with tretinoin; ZIANA with tretinoin; BENZACLIN (discontinued in FDA listings) with benzoyl peroxide
    EU (central) brands: none found
  24. coumamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  25. dactinomycin
    US brands: COSMEGEN (discontinued in FDA listings)
    EU (central) brands: none found
  26. daptomycin
    US brands: CUBICIN (discontinued in FDA listings), CUBICIN RF (discontinued in FDA listings), DAPZURA RT (discontinued in FDA listings)
    EU (central) brands: Cubicin, Daptomycin Hospira
  27. dihydrostreptomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  28. diproleandomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  29. dirithromycin
    US brands: DYNABAC (discontinued in FDA listings)
    EU (central) brands: none found
  30. duazomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  31. efrotomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  32. endomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  33. enramycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  34. enviomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  35. erythromycin
    US brands: ERY-TAB, ERYC, ERYTHRA-DERM, ERYTHROCIN, A/T/S (discontinued in FDA listings), AKNE-MYCIN (discontinued in FDA listings), BRISTAMYCIN (discontinued in FDA listings), C-SOLVE-2 (discontinued in FDA listings), E-BASE (discontinued in FDA listings), E-GLADES (discontinued in FDA listings), E-MYCIN (discontinued in FDA listings), E-SOLVE 2 (discontinued in FDA listings)
    21 moreEMGEL (discontinued in FDA listings), ERYC 125 (discontinued in FDA listings), ERYC SPRINKLES (discontinued in FDA listings), ERYCETTE (discontinued in FDA listings), ERYDERM (discontinued in FDA listings), ERYGEL (discontinued in FDA listings), ERYMAX (discontinued in FDA listings), ERYPAR (discontinued in FDA listings), ERYTHRO-STATIN (discontinued in FDA listings), ERYTHROCIN STEARATE (discontinued in FDA listings), ETHRIL 250 (discontinued in FDA listings), ETHRIL 500 (discontinued in FDA listings), ILOTYCIN (discontinued in FDA listings), PCE (discontinued in FDA listings), PFIZER-E (discontinued in FDA listings), R-P MYCIN (discontinued in FDA listings), ROBIMYCIN (discontinued in FDA listings), SANSAC (discontinued in FDA listings), STATICIN (discontinued in FDA listings), T-STAT (discontinued in FDA listings), WYAMYCIN S (discontinued in FDA listings)
    in combination: BENZAMYCIN with benzoyl peroxide; AKTIPAK (discontinued in FDA listings) with benzoyl peroxide
    EU (central) brands: none found
  36. flurithromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  37. fosfomycin
    US brands: CONTEPO, MONUROL (discontinued in FDA listings)
    EU (central) brands: none found
  38. fosmidomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  39. gamithromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  40. ganefromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  41. hachimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  42. hamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  43. heliomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  44. josamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  45. kanamycin
    US brands: KANTREX (discontinued in FDA listings), KLEBCIL (discontinued in FDA listings)
    EU (central) brands: none found
  46. kitasamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  47. laidlomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  48. lexithromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  49. lidimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  50. lincomycin
    US brands: LINCOCIN
    EU (central) brands: none found
  51. lividomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  52. lucimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  53. maridomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  54. midecamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  55. mikamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  56. mirincamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  57. mithramycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  58. mitomycin
    US brands: JELMYTO, MITOSOL, ZUSDURI, MITOZYTREX (discontinued in FDA listings), MUTAMYCIN (discontinued in FDA listings)
    EU (central) brands: none found
  59. mocimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  60. modithromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  61. nafithromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  62. natamycin
    US brands: NATACYN
    EU (central) brands: none found
  63. nebramycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  64. neomycin
    US brands: MYCIFRADIN (discontinued in FDA listings), NEO-FRADIN (discontinued in FDA listings), NEO-RX (discontinued in FDA listings), NEOBIOTIC (discontinued in FDA listings)
    in combination: CASPORYN HC with hydrocortisone + polymyxin b; COLY-MYCIN S with colistin + hydrocortisone + thonzonium; DEXASPORIN with dexamethasone + polymyxin b; LUMI-SPORYN with bacitracin + polymyxin b; MAXITROL with dexamethasone + polymyxin b; NEO-SYNALAR with fluocinolone acetonide; NEOSPORIN G.U. IRRIGANT with polymyxin b; OTICAIR with hydrocortisone + polymyxin b; COR-OTICIN (discontinued in FDA listings) with hydrocortisone; CORDRAN N (discontinued in FDA listings) with flurandrenolide; CORTISPORIN (discontinued in FDA listings) with bacitracin + hydrocortisone + polymyxin b; DEXACIDIN (discontinued in FDA listings) with dexamethasone + polymyxin b
    17 moreLANABIOTIC (discontinued in FDA listings) with bacitracin + lidocaine + polymyxin b; MYCITRACIN (discontinued in FDA listings) with bacitracin + polymyxin b; MYTREX A (discontinued in FDA listings) with triamcinolone acetonide; NEO-CORT-DOME (discontinued in FDA listings) with acetic acid + glacial + hydrocortisone; NEO-CORTEF (discontinued in FDA listings) with hydrocortisone; NEO-DELTA-CORTEF (discontinued in FDA listings) with prednisolone; NEO-HYDELTRASOL (discontinued in FDA listings) with prednisolone; NEO-MEDROL (discontinued in FDA listings) with methylprednisolone; NEO-MEDROL ACETATE (discontinued in FDA listings) with methylprednisolone; NEO-POLYCIN (discontinued in FDA listings) with bacitracin + gramicidin + polymyxin b; NEODECADRON (discontinued in FDA listings) with dexamethasone; NEOSPORIN (discontinued in FDA listings) with gramicidin + polymyxin b; OTOBIONE (discontinued in FDA listings) with hydrocortisone + polymyxin b; OTOCORT (discontinued in FDA listings) with hydrocortisone + polymyxin b; PEDIOTIC (discontinued in FDA listings) with hydrocortisone + polymyxin b; POLY-PRED (discontinued in FDA listings) with polymyxin b + prednisolone; STATROL (discontinued in FDA listings) with polymyxin b
    EU (central) brands: none found
  65. neutramycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  66. nogalamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  67. oleandomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  68. olivomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  69. paldimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  70. paromomycin
    US brands: HUMATIN (discontinued in FDA listings)
    EU (central) brands: none found
  71. paulomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  72. peliomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  73. peplomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  74. pirlimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  75. plicamycin
    US brands: MITHRACIN (discontinued in FDA listings)
    EU (central) brands: none found
  76. porfiromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  77. primycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  78. pristinamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  79. puromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  80. ranimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  81. relomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  82. retaspimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  83. ribostamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  84. rifamycin
    US brands: AEMCOLO (discontinued in FDA listings)
    EU (central) brands: none found
  85. rokitamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  86. roxithromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  87. rufocromomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  88. rutamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  89. salinomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  90. sedecamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  91. solithromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  92. sparsomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  93. spectinomycin
    US brands: TROBICIN (discontinued in FDA listings)
    EU (central) brands: none found
  94. spiramycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  95. stallimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  96. steffimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  97. streptomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  98. surotomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  99. talisomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  100. tanespimycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  101. telithromycin
    US brands: KETEK (discontinued in FDA listings)
    EU (central) brands: Ketek (withdrawn), Levviax (withdrawn)
  102. terdecamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  103. troleandomycin
    US brands: TAO (discontinued in FDA listings)
    EU (central) brands: none found
  104. trospectomycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  105. tulathromycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  106. vancomycin
    US brands: FIRVANQ KIT, TYZAVAN, VANCOCIN HYDROCHLORIDE, VANCOLED (discontinued in FDA listings), VANCOR (discontinued in FDA listings)
    EU (central) brands: none found
  107. viomycin
    US brands: VIOCIN SULFATE (discontinued in FDA listings)
    EU (central) brands: none found
  108. virginiamycin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Names with these letters that are not antibiotics, produced by Streptomyces strains (see also -kacin)

WHO lists these 2 names under -mycin, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In these names, WHO’s definition of -mycin does not apply.

  1. capreomycin
  2. tobramycin

Same group, without the stem

WHO also lists these 25 names under -mycin: group (c) of Part IV of the 2024 stem book, “INN which belong to the same group of pharmaceutical substances but in which the stem is not used”. They belong to the same group of substances as the group (a) names above, yet they do not carry -mycin, so the name alone does not reveal the group.

  1. aspartocin
  2. azidamfenicol
  3. candicidin
  4. cetofenicol
  5. chloramphenicol
  6. cloramfenicol pantotenate complex
  7. cycloserine
  8. daunorubicin
  9. fidaxomicin
  10. filipin
  11. kalafungin
  12. mirosamicin
  13. mitomalcin
  14. novobiocin
  15. nystatin
  16. ostreogrycin
  17. rifamide
  18. rifampicin
  19. rosaramicin
  20. streptoniazid
  21. streptonigrin
  22. streptovarycin
  23. thiamphenicol
  24. tylosin
  25. viridofulvin

Decode another name

Decoded

hamycin

Listed INNCarries the WHO stem -mycin

  • -mycinend of the nameWHO lists it hereWHO definition: antibiotics, produced by Streptomyces strains (see also -kacin)

“hamycin” is an INN that WHO lists under -mycin in the 2024 stem book. WHO’s 2024 stem book lists “hamycin” under -tricin as a name of the same group of substances in which the stem is not used (group c).

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -mycin (Part II B) and the 108 names (Part IV, group (a)), and the 2 not in accordance with it (group (b)) and 25 of the same group without the stem (group (c)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy